- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Early-stage venture capital firm OVP Venture Partners (OVP) announced today that partner Dave Chen will transition to part-time venture partner effective July 1, 2007. He will retain an economic interest in the firm's most recent two funds while moving to independently pursue opportunities in sustainability and new and emerging markets.
"Dave brought a high degree of energy and intelligence to OVP. He has tremendous passion in the areas of sustainability and emerging markets, and we encourage and support his pursuit of new opportunities in these areas," said Chad Waite, General Partner at OVP.
OVP is currently investing its seventh fund of $250 million and recently added two new partners to its investing team. The firm now has over $750 million in capital under management.
About OVP Venture Partners
For over 24 years, OVP Venture Partners has led the drive into new, high-growth technology markets in the Pacific Northwest. OVPís strategy of focusing on early stage investments in defined spaces has yielded proven results; the firmís record of 52 liquidity events Ė including 22 IPOs Ė leads the region. The OVP team has a passion for working with ground-breaking entrepreneurs and high-caliber investors, and is known for its track record and personal integrity. OVP has over $750 million in capital under management and is currently investing its seventh fund.
OVP has offices in Seattle and Portland and concentrates on opportunities at the intersection of technologyís next big waves and foundational strengths native to the region. The firmís recent activity has included deals in communications, software, security, semiconductors, digital biology, and nanotechnology.
The OVP team includes investing partners Chad Waite, Lucinda Stewart, Mark Ashida, Rick LeFaivre and Carl Weissman in Seattle and Gerry Langeler, John Hull and Dave Chen in Portland. Chad Waite serves on the Board of the National Venture Capital Association (NVCA).
For more information, please click here
OVP Venture Partners
Sara Morris, 206-851-5590
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Metamaterial device allows chameleon-like behavior in the infrared October 28th, 2016
The molecular mechanism that blocks membrane receptors has been identified: The work in which the Ikerbasque researcher of the Biofisika Institute Xabier Contreras has participated has been published in the journal Cell October 27th, 2016
Imaging where cancer drugs go in the body could improve treatment October 26th, 2016